Carlo D. Santos-Ocampo, MD
Clinical, Nuclear and Interventional Cardiology
About Dr. Santos-Ocampo
Dr. Santos-Ocampo completed his undergraduate degree at the University of the Philippines with a bachelor of science degree, magna cum laude. He then received his medical degree from the University of the Philippines School of Medicine in 1984.
Dr. Santos-Ocampo relocated to Providence, Rhode Island, where he completed an internship and residency in internal medicine, followed by a fellowship in cardiology—all through the Brown University School of Medicine. He then was honored to be invited to serve as a faculty staff member in the Division of Cardiology at The Miriam Hospital and the Brown University Program in Medicine.
Santos-Ocampo returned to the Philippines to practice cardiology for nearly ten years from 1993 to 2002 where he pioneered the development of nuclear and interventional cardiology. Because of his efforts, he was recognized and awarded as one of the “Ten Outstanding Young Men” in the Philippines. Dr. Santos-Ocampo emphasizes preventive cardiology and uses the appropriate complementary state of the art non-invasive diagnostic modalities before considering minimally invasive approaches such as heart catheterizations and coronary stenting.
Dr. Santos-Ocampo relocated to Naples, Florida in 2002. He prides himself in providing the highest level of compassionate care and individualizing his approach for every patient. He feels so privileged that patients entrust their lives to him and feels it is his duty to make an impact regardless of their level of cardiac care needed.
CONTACT INFORMATION
Rooney Heart Institute at NCH
399 9th Street North
Suite 300
Naples, FL 34102
EDUCATION
• University of Philippines
POST-GRADUATE TRAINING
• The Philippine General Hospital
• Brown University School of Medicine
• Miriam Hospital/Brown University
PUBLICATIONS
1. Santos-Ocampo CD, Elion JL. An irregular supraventricular tachycardia. Choices in Cardiology 1992;6:97-98.
2. Santos-Ocampo CD. ST-segment elevation and diaphoresis. Choices in Cardiology 1993;7:60-63
3. Herman SD, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messinger DE, Cloutier DJ, Ahlberg AW, Heller GV. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994;73:164-169.
4. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, Heller GV. Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imaging. J Nucl Cardiol 1994;1:57-64.
5. Santos-Ocampo CD, Sadaniantz A, Elion JL, Garber CE, Malone LL, Parisi AF. Echocardiographic assessment of the cardiac anatomy in patients with multifocal atrial tachycardia: a comparison with atrial fibrillation. Am J Med Sci 1994;307(4)264-268.
6. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, Heller GV. Exercise, dipyridamole, and adenosine yield comparable technetium-99m sestamibi tomographic imaging. Phil J Cardiovasc Med 1994;8:37-44.
7. Alimurung BN, Santos-Ocampo CD, Rosas N. Nuclear imaging in the evaluation of restenosis. Asian-Pacific Society of Interventional Cardiology 1994;1:4-5.
8. Santos-Ocampo CD. Nuclear cardiology following percutaneous transluminal coronary angioplasty. Current Cardiology 1995;3:3-5.
9. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo CD, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202-8
10. Santos-Ocampo CD, Kirdar JA, Josa M, Sharma SC. Long-term follow-up of Reiter’s syndrome with aortic regurgitation and complete heart block. Annual Scientific Meeting, American College of Physicians, Providence, RI, 1990.
11. Herman SD, Labresh KA, Santos-Ocampo CD, Garber CE, Messinger DE, Barbour MM, Heller GV. Comparison of dobutamine and exercise using technetium-99m sestamibi for the evaluation of coronary artery disease. J Nucl Med 1992;33:951.
12. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, Heller GV. Adenosine, dipyridamole and exercise yield comparable technetium-99m sestamibi SPECT images. J Am Coll Cardiol 1993; 21:420A.
13. Santos-Ocampo CD, Herman SD, McClellan JR, Garber CE, Cloutier DJ, Heller GV. Prognostic significance of dipyridamole technetium-99m sestamibi SPECT imaging for the evaluation of ischemic heart disease. J Am Coll Cardiol 1993;21:90A.
14. Herman SD, McClellan JR, Santos-Ocampo CD, McNulty CM, Garber CE, Cloutier DJ, Ahlberg AW, Messinger DE, St. Laurent LJ, Heller GV. Comparison of simultaneous dobutamine technetium-99m sestamibi imaging and echocardiography in patients with reactive airways disease. J Am Coll Cardiol 1993;21:208A.
15. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, Heller GV. Adenosine, dipyridamole and exercise yield comparable technetium-99m sestamibi SPECT images. First International Congress of Nuclear Cardiology, Cannes France, 1993.
16. McClellan JR, Santos-Ocampo CD, Herman SD, Garber CE, Cloutier DJ, Heller GV. How do physicians utilize dipyridamole technetium sestamibi myocardial perfusion imaging? First International Congress of Nuclear Cardiology, Cannes France, 1993.
17. Herman SD, Santos-Ocampo CD, McClellan JR, LaBresh KA, McNulty CM, Garber CE, Barbour MM, Messinger DE, Heller GV. Dobutamine technetium-99m sestamibi SPECT imaging for the evaluation of coronary artery disease. First International Congress of Nuclear Cardiology, Cannes, France, 1993.
18. Heller GV, Herman SD, Santos-Ocampo CD, Garber CE, Cloutier DJ, McClellan JR. Detection of ischemia by dipyridamole technetium-99m sestamibi SPECT imaging predicts future cardiac events. First International Congress of Nuclear Cardiology, Cannes, France, 1993.
19. Santos-Ocampo CD, Elion JL, Garber CE, Malone LL, Parisi AF. Echocardiographic assessment of the cardiac anatomy in multifocal atrial tachycardia as compared with atrial fibrillation. The American Federation of Clinical Research, Washington, DC, 1993.
20. Herman SD, Santos-Ocampo CD, McClellan JR, Cloutier DJ, Garber CE, Baron JI, Travin MI, Heller GV. Dipyridamole technetium-99m sestamibi SPECT myocardial perfusion imaging-prognostic implications. J Nucl Med 1993;34:85P.
21. Herman SD, Santos-Ocampo CD, Garber CE, Barbour MM, LaBresh KA, Cloutier DJ, Messinger DE, Heller GV. Beta blocker therapy does not affect dobutamine technetium-99m sestamibi imaging. J Nucl Med 1993;34:152P.
22. Gallagher JG, McClellan JR, Herman SD, Santos-Ocampo CD, Garber CE, Cloutier DJ, Baron JI, Travin MI, Heller GV. Significance of transient dipyridamole induced left ventricular cavity dilatation as assessed by technetium-99m sestamibi SPECT imaging. J Nucl Med 1993;34:75P.
23. Santos-Ocampo CD, Villacorta EV, Mendoza FT, Mangubat NV, Torres JF. Observer variability in exercise Tc-99m sestamibi SPECT imaging among South East Asians. 6th World Congress of the World Federation of Nuclear Medicine and Biology. Sydney, Australia. October 23-28, 1994.
24. Santos-Ocampo CD, Camara AD, Mendoza FT, Villacorta EV. Excellent risk stratification using an abbreviated ”exercise-only” technetium-99m SPECT perfusion imaging protocol. J Nucl Cardiol 1995;2:S61.
25. Rosas NL, Santos-Ocampo CD, Anastacio RV, Talavera DL, Lopez GA, Barril JB, Black D, Garcia JM. The feasibility of coronary artery surgery performed by an out-of-state surgical team. 23rd Congress of the International Society of Internal Medicine. Manila, Philippines. February 1-6, 1996.
26. Cubeddu RJ et al. Uninterrupted continuation of VV-ECMO without anticoagulation for 44 days in COVID 19 ARDS: A precarious quandary. J Cardiothoracic Vasc Anesthesia. Apr 2022.
VERIFIED PATIENT REVIEWS
The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy.
